Pathologic features and clinical treatment of sarcomatoid intrahepatic cholangiocarcinoma

IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Intractable & rare diseases research Pub Date : 2023-01-01 DOI:10.5582/irdr.2023.01094
Xiaoli Xie, Nannan Lai, Yuanyuan Yang, Jinwei Zhang, Jianmin Qin, Xia Sheng
{"title":"Pathologic features and clinical treatment of sarcomatoid intrahepatic cholangiocarcinoma","authors":"Xiaoli Xie, Nannan Lai, Yuanyuan Yang, Jinwei Zhang, Jianmin Qin, Xia Sheng","doi":"10.5582/irdr.2023.01094","DOIUrl":null,"url":null,"abstract":"The current study examined sarcomatoid intrahepatic cholangiocarcinoma (S-iCCA). S-iCCA was a more aggressive subtype of intrahepatic cholangiocarcinoma (iCCA). Early detection and complete resection of tumors are very important. Reported here is a case of S-iCCA, and the diagnosis and treatment of S-iCCA are discussed. The patient underwent a tumor resection and was treated with chemotherapy and molecularly targeted drugs after surgery. The clinical pathologic features and treatment of S-iCCA are discussed based on the literature. An immunohistochemical examination revealed positivity for cytokeratin 7 (CK7), CK-pan, vimentin, and CK19 and negativity for hepatocyte paraffin 1 (HepPar-1) in sarcomatoid cells. This case suggests that the particular molecular characteristics of sarcomatoid cells have great clinical diagnostic value, and comprehensive treatment of S-iCCA based on surgery is described.","PeriodicalId":14420,"journal":{"name":"Intractable & rare diseases research","volume":"251 1","pages":"0"},"PeriodicalIF":1.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intractable & rare diseases research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5582/irdr.2023.01094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

The current study examined sarcomatoid intrahepatic cholangiocarcinoma (S-iCCA). S-iCCA was a more aggressive subtype of intrahepatic cholangiocarcinoma (iCCA). Early detection and complete resection of tumors are very important. Reported here is a case of S-iCCA, and the diagnosis and treatment of S-iCCA are discussed. The patient underwent a tumor resection and was treated with chemotherapy and molecularly targeted drugs after surgery. The clinical pathologic features and treatment of S-iCCA are discussed based on the literature. An immunohistochemical examination revealed positivity for cytokeratin 7 (CK7), CK-pan, vimentin, and CK19 and negativity for hepatocyte paraffin 1 (HepPar-1) in sarcomatoid cells. This case suggests that the particular molecular characteristics of sarcomatoid cells have great clinical diagnostic value, and comprehensive treatment of S-iCCA based on surgery is described.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肉瘤样肝内胆管癌的病理特点及临床治疗
目前的研究检查了肝内胆管肉瘤样癌(S-iCCA)。S-iCCA是一种更具侵袭性的肝内胆管癌(iCCA)亚型。肿瘤的早期发现和完全切除非常重要。本文报告1例S-iCCA,并对S-iCCA的诊断和治疗进行讨论。患者接受肿瘤切除术,术后接受化疗和分子靶向药物治疗。结合文献对S-iCCA的临床病理特点及治疗进行探讨。免疫组化检查显示,类肉瘤细胞中细胞角蛋白7 (CK7)、CK-pan、vimentin和CK19阳性,肝细胞石蜡蛋白1 (HepPar-1)阴性。本病例提示肉瘤样细胞的特殊分子特征具有很大的临床诊断价值,并描述了以手术为基础的S-iCCA的综合治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Intractable & rare diseases research
Intractable & rare diseases research MEDICINE, GENERAL & INTERNAL-
CiteScore
2.10
自引率
0.00%
发文量
29
期刊最新文献
Current status and challenges of biologic targeted therapy for myasthenia gravis in China. Foods for special medical purposes for the dietary therapy of rare diseases: Current status and future prospects. Progress in the research and pharmacoeconomic evaluation of drugs and devices for rare diseases in China. Health technology assessment and medical insurance access for rare disease drugs in China: A policy review with quantitative insights from publicly available data. Visualization analysis of the use of traditional Chinese medicine in the diagnosis and treatment of rare diseases in mainland China based on CiteSpace.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1